FRNM

Conviction 0HealthcareScan · Fri, Sep 25, 2026

Freenome, Inc. (FRNM) closed at $16.00 (-0.06%) on Sep 25, 2026. RSI(14) 57, -6.5% from its 52-week high, +23.0% year to date. Sector: Healthcare.

FRNM$16.00-0.06%

ResistanceSupportVol 14

Vol MA14 983.82K

Jul 21Aug 3Aug 17Aug 28Sep 14Sep 25

Freenome, Inc.

Price16.00

Change-0.06%

Gap-1.56%

Rel volume0.53×

Avg volume1.05M

Avg $ vol16.74M

SMA 2015.67

SMA 50—

SMA 200—

Price vs 50—

Price vs 200—

MA stack—

50/200 cross—

Supertrendup · 14.22

RSI (14)57

MACD hist-0.06

MACD crossbear · 2d

Stoch %K / %D54 / 51

ADX (14)34

+DI / −DI27 / 17

RSI divergenceBearish

MACD divergence—

ATR %5.79%

ADR %6.02%

52w high17.11

52w low9.99

From 52w high-6.49%

Above 52w low+60.16%

New 52w highNo

SqueezeOff

Bollinger width20.51%

%B0.60

Donchian pos59.35%

Donchian high17.50

Donchian low13.81

AVWAP (52w high)16.18

vs AVWAP high-1.11%

AVWAP (52w low)14.13

vs AVWAP low+13.24%

OBV trendUp

Chaikin MF (20)0.35

Today vs 20d0.53×

Avg vol (14d)993.42K

Avg vol (20d)1.05M

Avg $ vol (20d)16.74M

Market cap142.58M

RS Rating—

RS 3m (vs SPY)—

RS 6m (vs SPY)—

RS line new highNo

Trend template—

Technical rank78.8

1 week-6.49%

1 month+13.56%

3 months—

6 months—

1 year—

YTD+22.98%

P/E170.25

P/B-22.64

P/S—

P/FCF—

EPS—

Div yield—

ROE-13.30%

ROA0.98%

Debt/Eq—

Current0.20

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target18.00

Target upside12.50%

Analyst ratingBuy

Institutional8.19%

Ent. value142.14M

Revenue—

Net income-114.94K

Gross profit—

Free cash flow—

Industry—

ExchangeNasdaq

Shares out—

Employees—

Listed—

Free float5.72M

Float %64.2%

Short interest1.53M

Days to cover1.7d

Short volume64.4%

Squeeze score65 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank78.8 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance17.34

Support12.83

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in FRNM

All disclosures →

No recent disclosed trades by Congress in FRNM. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in FRNM

Insider	Side	Shares	Value	Traded	Filed
ALTMAN MICHAEL SETH Insider · Common Stock · 2026-07-20	Convert	2.07M	—	2026-07-20	2026-07-22
ALTMAN MICHAEL SETH Insider · Class B Ordinary Shares · 2026-07-20	Convert	2.07M	—	2026-07-20	2026-07-22
PERCEPTIVE ADVISORS LLC 10% owner · Common Stock · 2026-07-20	Grant	5.5M	$55M	2026-07-20	2026-07-22
RA CAPITAL MANAGEMENT, L.P. Director · Common Stock · 2026-07-20	Grant	6.56M	—	2026-07-20	2026-07-22
RA CAPITAL MANAGEMENT, L.P. Director · Common Stock · 2026-07-20	Grant	970.95K	—	2026-07-20	2026-07-22
RA CAPITAL MANAGEMENT, L.P. Director · Common Stock · 2026-07-20	Grant	553.7K	—	2026-07-20	2026-07-22
RA CAPITAL MANAGEMENT, L.P. Director · Common Stock · 2026-07-20	Grant	908.1K	—	2026-07-20	2026-07-22
RA CAPITAL MANAGEMENT, L.P. Director · Common Stock · 2026-07-20	Grant	367.43K	—	2026-07-20	2026-07-22
RA CAPITAL MANAGEMENT, L.P. Director · Common Stock · 2026-07-20	Grant	4.92M	$49M	2026-07-20	2026-07-22
RA CAPITAL MANAGEMENT, L.P. Director · Common Stock · 2026-07-20	Grant	336.96K	$3.4M	2026-07-20	2026-07-22

SEC filings

EDGAR filings in FRNM · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.